HDFC Life and Bank of Maharashtra Highlighted as Top Stock Picks
Brokerage firms recommend HDFC Life, Bank of Maharashtra, and others as promising investment opportunities amid market volatility.
HDFC Life's target price set at Rs 608-610 with a stop loss at Rs 530.
Bank of Maharashtra shows a positive trend with a target price of Rs 91-96.
Fortis Healthcare is positioned for recovery with a target price of Rs 892.
In the midst of fluctuating market conditions, several domestic brokerage firms, including Choice Broking and SMC Global Securities, have identified key stocks as potential buys. Among these are HDFC Life Insurance, Bank of Maharashtra, Mayur Uniquoters, and Fortis Healthcare, which are recommended based on robust technical indicators and market analysis.
Mayur Uniquoters is noted for its bullish breakout potential, having recently surpassed a resistance level around Rs 750-760. Analysts suggest that if the stock maintains trading above Rs 780-790, it could reach target prices between Rs 875-885. The stock's support levels are identified at Rs 740-750, with a stop loss recommended at Rs 720, indicating a strategic entry point for investors.
Bank of Maharashtra is also on the radar, showcasing a strong upward trend with a target price of Rs 91-96. The stock has demonstrated a consistent higher-high and higher-low pattern on its weekly chart. Analysts recommend buying around Rs 82.75, with a stop loss at Rs 80, as it continues to find support near its 20-week exponential moving average (EMA). Maintaining above the Rs 76 support level is crucial for sustaining its positive momentum.
HDFC Life Insurance is exhibiting a classic double-bottom pattern, with strong demand observed near the Rs 510-515 range. The stock has rebounded to around Rs 560, and a decisive close above Rs 567 could lead to a target of Rs 608-610. Investors are advised to consider buying above this breakout level while keeping a stop loss at Rs 530.
Lastly, Fortis Healthcare is showing signs of recovery after a significant correction from its previous highs. It is currently trading near a crucial support zone of Rs 750, with a target price of Rs 892. Analysts suggest that buying around Rs 794, with a stop loss at Rs 745, could be beneficial as the stock stabilizes and shows increasing buying interest. Overall, these recommendations reflect a strategic approach to navigating current market volatility.
